IMMG — Immage Biotherapeutics Cashflow Statement
0.000.00%
Last trade - 00:00Basic MaterialsHighly SpeculativeMicro Cap
- $0.00m
- $0.00m
Annual cashflow statement for Immage Biotherapeutics, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2012 September 30th | 2013 September 30th | 2014 September 30th | 2015 August 31st | 2016 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 11 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.002 | -0.012 | -0.019 | -0.054 | -0.216 |
| Depreciation | |||||
| Amortisation | |||||
| Changes in Working Capital | 0.001 | 0 | 0.001 | 0.001 | -0.008 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.001 | -0.012 | -0.018 | -0.052 | -0.216 |
| Capital Expenditures | — | — | — | -0.041 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | — | — | -0.041 | 0 |
| Financing Cash Flow Items | -0.005 | 0.005 | 0 | 0 | -0.006 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.006 | 0.014 | 0.013 | 0.124 | 0.38 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.005 | 0.002 | -0.005 | 0.03 | 0.164 |